A Study of LY4086940
Phase 1
201
about 1 year
18–65
5 sites in FL, GA, TX
What this study is about
Researchers are testing a treatment called LY4086940 in people who are healthy, overweight or obese, or have type 2 diabetes. The trial will last about 372 days and involve visits to the clinic over several weeks. It is evaluating how safe and well-tolerated this treatment is.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take LY4086940
- 2.Take Placebo
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Number of Participants with One or More Serious Adverse Events (SAE) Considered by the Investigator to be Related to Study Drug Administration
Secondary: PK: Area Under the Concentration Versus Time Curve (AUC) of LY4086940, Pharmacokinetics (PK): Maximum Observed Concentration (Cmax) of LY4086940
Endocrinology